Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Crazy About Ameristar Casinos, Inc. (NASDAQ:ASCA)

Is Ameristar Casinos, Inc. (NASDAQ:ASCA) a safe investment today? Investors who are in the know are becoming hopeful. The number of long hedge fund positions rose by 7 lately.

At the moment, there are a multitude of indicators shareholders can use to watch Mr. Market. Two of the most useful are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the best investment managers can outpace their index-focused peers by a healthy margin (see just how much).

Ameristar Casinos, Inc.

Just as key, bullish insider trading activity is another way to parse down the world of equities. Just as you’d expect, there are lots of stimuli for a corporate insider to get rid of shares of his or her company, but only one, very clear reason why they would buy. Various empirical studies have demonstrated the market-beating potential of this strategy if you understand what to do (learn more here).

Consequently, let’s take a gander at the key action regarding Ameristar Casinos, Inc. (NASDAQ:ASCA).

How are hedge funds trading Ameristar Casinos, Inc. (NASDAQ:ASCA)?

Heading into 2013, a total of 26 of the hedge funds we track were bullish in this stock, a change of 37% from one quarter earlier. With hedge funds’ sentiment swirling, there exists an “upper tier” of key hedge fund managers who were boosting their stakes considerably.

According to our comprehensive database, PAR Capital Management, managed by Paul ReederáandáEdward Shapiro, holds the largest position in Ameristar Casinos, Inc. (NASDAQ:ASCA). PAR Capital Management has a $69 million billion position in the stock, comprising 3% of its 13F portfolio. Coming in second is Balyasny Asset Management, managed by Dmitry Balyasny, which held a $42 million position; the fund has 1.1% of its 13F portfolio invested in the stock. Some other hedgies that are bullish include Don Morgan’s Brigade Capital, Daniel S. Och’s OZ Management and Robert Emil Zoellner’s Alpine Associates.

With a general bullishness amongst the heavyweights, key hedge funds have been driving this bullishness. Balyasny Asset Management, managed by Dmitry Balyasny, established the most outsized position in Ameristar Casinos, Inc. (NASDAQ:ASCA). Balyasny Asset Management had 42 million invested in the company at the end of the quarter. Robert Emil Zoellner’s Alpine Associates also initiated a $13 million position during the quarter. The following funds were also among the new ASCA investors: Clint Carlson’s Carlson Capital, Jeffrey Smith’s Starboard Value LP, and Alexander Mitchell’s Scopus Asset Management.

What have insiders been doing with Ameristar Casinos, Inc. (NASDAQ:ASCA)?

Insider purchases made by high-level executives is best served when the company in focus has seen transactions within the past half-year. Over the latest 180-day time period, Ameristar Casinos, Inc. (NASDAQ:ASCA) has experienced zero unique insiders purchasing, and 2 insider sales (see the details of insider trades here).

With the results exhibited by Insider Monkey’s studies, everyday investors should always keep an eye on hedge fund and insider trading activity, and Ameristar Casinos, Inc. (NASDAQ:ASCA) applies perfectly to this mantra.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!